Neuroscience
positron emission tomographic scan
100%
Endorphin
79%
In Vivo
73%
Amphetamine
72%
Translocator Protein
66%
Multiple Sclerosis
64%
Major Depressive Disorder
62%
Panic Disorder
57%
Carfentanil
51%
Depressive Disorder
39%
Bipolar Disorder
34%
Receptor
33%
Antidepressant
30%
Metabolic Pathway
29%
Psychiatry
28%
Negative Syndrome
28%
Blood Plasma
28%
Positive Syndrome
28%
Functional Magnetic Resonance Imaging
24%
μ-Opioid Receptor
24%
Cell Excitability
24%
Radioligand
23%
Magnetization Transfer
23%
Quetiapine
21%
Positron Emission Tomography
20%
Atypical Antipsychotic
18%
Hypothalamic-Pituitary-Adrenal Axis
18%
Synaptic Transmission
18%
Functional Connectivity
17%
C-Reactive Protein
17%
Hypothalamus
16%
Hostility
15%
Agonist
15%
Treatment-Resistant Depression
14%
Dopamine Receptor D3
14%
Methylene Blue
14%
Duloxetine
14%
5-HTTLPR
14%
Myelin
14%
Magnetic Resonance Imaging
14%
Body Mass Index
14%
Mood Disorder
14%
Molecular Imaging
14%
Serotonin Release
14%
Neurotrauma
14%
Neuroendocrinology
14%
Acetate
14%
Gray Matter Volume
14%
Psilocybin
14%
Dyspnea
14%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
49%
Amphetamine
45%
Antidepressant
44%
Olanzapine
44%
Endorphin
43%
Diseases
40%
Quetiapine
34%
Major Depression
32%
Atypical Antipsychotics
32%
Dexamphetamine
31%
Tolerability
30%
Ziprasidone
29%
Clozapine
29%
Carbon Dioxide
28%
Negative Syndrome
27%
Carfentanil
24%
Risperidone
23%
μ-Opioid Receptor
23%
Clinical Trial
21%
Opiate Receptor
20%
Psychotropic Agent
20%
Carbon 11
20%
Receptor
19%
Therapeutic Drug Monitoring
19%
Antipsychotic Drug
19%
Positive Syndrome
17%
Depressive Disorder
17%
Toxic Injury
16%
Base
15%
Serotonin
15%
Aripiprazole
15%
Side Effect
14%
Treatment Resistant Depression
14%
Clinical Pharmacokinetics
14%
Clinical Pharmacology
14%
Pharmacotherapy
14%
Tryptophan
14%
Psychotomimetic
14%
Self Poisoning
14%
Concomitant Drug
14%
Naxagolide
14%
Raclopride
14%
Lurasidone
14%
Drug Induced Psychosis
14%
Duloxetine
14%
Psilocybin
14%
Symptomatology
11%
Amisulpride
10%
Cariprazine
9%
Asenapine
9%
Medicine and Dentistry
Carbon Dioxide
43%
Antidepressant
30%
Drug Abuse
28%
Diseases
28%
DSM-IV
20%
Panic Disorder
18%
Volunteer
18%
Base
18%
Medicine
15%
Treatment Resistant Depression
14%
Cost-Effectiveness Analysis
14%
Quetiapine
14%
Multiple Sclerosis
14%
Patient with Depression
14%
Psychiatric Diagnosis
14%
Negative Affectivity
14%
Carbon Dioxide Breathing
14%
Factor A
14%
Psychiatry
14%
Polyethylene Terephthalate
14%
Somatics
14%
Psychotomimetic
14%
Psilocybine
14%
Subclinical Hypothyroidism
14%
Thyroxine
14%
Health Status
14%
Functional Magnetic Resonance Imaging
14%
Recurrent Disease
9%
Involuntary Treatment
9%
Factor Analysis
9%
Pathophysiology
9%
Lipid Metabolism
9%
Thyroid Disease
9%
Short Form 36
9%
Health Care Cost
9%
Clinical Study
9%
Depressive Disorder
8%
Magnetization Transfer
8%
Blood-Oxygen-Level Dependent
8%
Visual Analog Scale
7%
Mitochondrial Membrane Transport Protein
7%
Acidosis
7%
Symptomatology
6%
Interleukin 6
5%
Treatment Response
5%
Brain Blood Flow
5%
Medial Prefrontal Cortex
5%
Arterial Spin Labeling
5%
